Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation

Emily C Suter1, Eva M Schmid2, Andrew R Harris3

  • 1Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA; UC Berkeley/UC San Francisco Graduate Group in Bioengineering, Berkeley, CA, USA.

Cell Reports
|August 25, 2021
PubMed

Insights

Macrophage phagocytosis decisions in cancer immunotherapy depend on the ratio of activating to inhibitory signals, not just absolute levels. A 10:1 activating to inhibitory ligand ratio is crucial for effective tumor cell clearance.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Signaling

Background:

  • Cancer immunotherapies leverage macrophages by modulating Fcγ receptors (FcγRs) and SIRPα-CD47 interactions.
  • The integration of competing activating and inhibitory signals in macrophages remains poorly understood.
  • Effective titration of immune responses in immunotherapy requires understanding signal integration.

Purpose of the Study:

  • To investigate how macrophages integrate competing activating (FcγR) and inhibitory (SIRPα-CD47) signals.
  • To determine the critical ratio of activating to inhibitory ligands for macrophage phagocytosis.
  • To explore the implications of ratiometric signaling for cancer immunotherapy.

Main Methods:

  • Utilized endogenous and chimeric receptors to model macrophage activation.
  • Quantified phagocytosis of antibody-opsonized targets with varying ligand densities.
  • Assessed FcγR phosphorylation and phosphatase recruitment in response to ligand engagement.

Main Results:

  • Macrophage phagocytic activity is governed by the ratio of activating to inhibitory ligands, not absolute densities.
  • An activating to inhibitory ligand ratio of at least 10:1 is necessary for phagocytosis of CD47-inhibited targets.
  • Lower ratios reduce FcγR phosphorylation due to inhibitory phosphatases recruited by SIRPα-CD47.

Conclusions:

  • Ratiometric signaling is critical for macrophage-mediated phagocytosis of tumor cells.
  • Modulating SIRPα signaling can alter phagocytic responses.
  • Balancing targeting and blocking antibodies is essential for optimizing macrophage phagocytosis in cancer immunotherapy.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.1K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
6.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.6K